INOZYME PHARMA INC (INZY) Stock News

USA - NASDAQ:INZY - US45790W1080 - Common Stock

4 USD

+0.01 (+0.25%)

Last: 6/30/2025, 8:00:02 PM

3.99 USD

-0.01 (-0.25%)

After Hours: 6/30/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

INZY Latest News, Press Relases and Analysis

All

Press Releases

3 months ago - By: BioMarin Pharmaceutical Inc. - Mentions: BMRN

News Image

BioMarin Announces Completion of Acquisition of Inozyme

3 months ago - By: Inozyme Pharma Inc.

Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders

3 months ago - By: Inozyme Pharma Inc.

Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders

4 months ago - By: Halper Sadeh LLC - Mentions: TXNM NYSE PTIX

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INZY, TXNM, SVT, PTIX on Behalf of Shareholders

4 months ago - By: Benzinga - Mentions: HCTI TSSI AFMD ZENV ...

US Stocks Edge Higher; Consumer Sentiment Falls In May

4 months ago - By: Brodsky & Smith LLC - Mentions: TXNM NYSE PTIX

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXNM Energy, Inc. (NYSE - TXNM), Servotronics, Inc. (NYSE American - SVT), Protagenic Therapeutics, Inc. (Nasdaq – PTIX)

4 months ago - By: Zacks Investment Research - Mentions: BMRN MRNA NVAX PRME

Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More

4 months ago - By: Kahn Swick & Foti, LLC

INOZYME PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inozyme Pharma, Inc. - INZY

4 months ago - By: Brodsky & Smith LLC - Mentions: TXNM SVT PTIX BMRN

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXNM Energy, Inc. (NYSE - TXNM), Servotronics, Inc. (NYSE American - SVT), Protagenic Therapeutics, Inc. (Nasdaq – PTIX)

4 months ago - By: Zacks Investment Research - Mentions: BMRN AGEN ADPT

BioMarin Offers to Buy Inozyme for $270M to Boost Enzyme Therapy Biz

4 months ago - By: Halper Sadeh LLC - Mentions: SWTX NVEE CHTR

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWTX, NVEE, CHTR, INZY on Behalf of Shareholders

4 months ago - By: Yahoo Finance - Mentions: BMRN

BioMarin Expands Rare Disease Portfolio with $270M Inozyme Acquisition

4 months ago - By: Yahoo Finance - Mentions: MS TWLO AVGO BMRN ...

Morgan Stanley Analyst Maintains Buy Rating on Twilio (TWLO) Stock, Keeps $117 PT

4 months ago - By: Yahoo Finance - Mentions: LC GOOG RY BMO ...

This Fintech Is Building an AI-Powered Bank on the Cheap -- and Trades for Less Than Book Value

4 months ago - By: Yahoo Finance - Mentions: BMRN

Leerink bullish on BioMarin following Inozyme deal, expects additional BD

4 months ago - By: Yahoo Finance - Mentions: BNS FLO BMO ACRV ...

Scotiabank price target raised to C$71 from C$70 at BofA

4 months ago - By: Yahoo Finance - Mentions: CM BMO MCD BNS ...

CIBC price target raised to C$100 from C$98 at BofA

4 months ago - By: Yahoo Finance - Mentions: GM NVDA BMRN WMT ...

Great News for General Motors Investors

4 months ago - By: Yahoo Finance - Mentions: VZ FIS SCHW HOOD ...

4 Best Benefits of Bank-Backed Financial Planning Tools and How You Should Use Them

4 months ago - By: Benzinga - Mentions: FLO GLOB TSSI QUBT ...

Gold Down Over 1%; Flowers Foods Posts Weak Earnings

4 months ago - By: Stocktwits - Mentions: BMRN

Inozyme Stock Rockets 179% After BioMarin Agrees To Acquire The Company For $270M: Retail Sentiment Brightens

4 months ago - By: Halper Sadeh LLP - Mentions: CHTR

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHTR and INZY on Behalf of Shareholders

4 months ago - By: Halper Sadeh LLC

INZY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Inozyme Pharma, Inc. Is Fair to Shareholders

4 months ago - By: Investor's Business Daily - Mentions: BMRN

BioMarin Bolsters Pipeline With $270 Million Inozyme Pharma Takeover

4 months ago - By: Ademi & Fruchter LLP

Shareholder Alert: The Ademi Firm investigates whether Inozyme Pharma, Inc. is obtaining a Fair Price for its Public Shareholders

4 months ago - By: BioMarin Pharmaceutical Inc. - Mentions: BMRN

BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma

4 months ago - By: Inozyme Pharma Inc.

Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights

4 months ago - By: Inozyme Pharma Inc.

Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights

5 months ago - By: Inozyme Pharma Inc.

Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency

5 months ago - By: Inozyme Pharma Inc.

Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency

6 months ago - By: Inozyme Pharma Inc.

Inozyme Pharma to Participate in the 24th Annual Needham Virtual Healthcare Conference

6 months ago - By: Inozyme Pharma Inc.

Inozyme Pharma to Participate in the 24th Annual Needham Virtual Healthcare Conference

7 months ago - By: Inozyme Pharma Inc.

Inozyme Pharma Reports Full Year 2024 Financial Results and Announces Strategic Prioritization of ENPP1 Deficiency Pivotal Program and Recent Business Highlights